FDA Advisors Back Fecal Microbiome Treatment for Recurrent C. Diff

(MedPage Today) -- An FDA advisory board recommended the agency approve a fecal microbiota transfer (FMT) product for recurrent Clostridium difficile infections.
By a vote of 13-4 on Thursday, the Vaccines and Related Biological Products Advisory...